Abstract
Background and objective Tobacco addiction is a major public health problem. Numerous scientific studies have been conducted on the harms of tobacco products. However, the number of intervention studies investigating the effect of long-term awareness of the harm of tobacco products on the Fagerström nicotine addiction test (FTND), carbon monoxide (CO), carboxyhemoglobin (COHb) and respiratory function test (RFT) are limited. Our goal is to investigate the impact of long-term scientific awareness on these parameters.
Participant and Method The study was designed an intervention study on active and passive smoking participants and their control groups. Intervention groups were given seminar program (up-to-date literature information and images on the harms of tobacco products) for eight weeks. Control groups were not given any training on the harms of tobacco products. Intervention groups were measured 8 times (FNBT, CO, COHb and SFT). Control groups were measured only in the first and last week.
Result When comparing the first and last weeks in active smoker intervention group (ASIG), the difference between FTND, FEV1, CO, and COHb parameters was observed to be statistically significant. The highest decrease in ASIG was in CO (60%) parameter and the highest increase was in the FEV1(%10) parameter. There was a significant difference between FEV1, FVC, FEV1/FVC, and CO parameters of passive smokers intervention group (PSIG). The highest decrease in PSIG was in the CO parameter (%65.8) and the highest increase was in the FVC (%10) parameter.
Conclusion Awareness programs may reduce the severity of addiction in active smokers and may help protect passive smokers. In the absence of any awareness, it may not positively change. As awareness increases, positive changes in some vital parameters may be possible. Up-to-date programs and policies are needed to make easy and sustainable awareness of both active and passive smoking.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by Selcuk University Scientific Research Projects Unit Project Number: 17202041
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical committee approval was obtained from the Ethics Committee of Selcuk University (2017/11).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
.
